MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, NEPH had $97K increase in cash & cash equivalents over the period.

Cash Flow Overview

Change in Cash
$97K

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Cash Flow
2025-09-30
2025-06-30
Total net revenues
14,060 -
Cost of goods sold
5,196 -
Gross margin
8,864 -
Research and development
944 -
Selling, general and administrative
6,684 -
Other operating expenses
108 -
Total operating expenses
7,736 -
Operating income (loss)
1,128 -
Total other expense (income), net
16 -
Income (loss) before income taxes
1,144 -
Income tax expense
12 -
Net income (loss)
337 795
Depreciation of property and equipment
12 30
Amortization of intangible assets, license and supply agreement and finance lease right-of-use asset
22 43
Stock-based compensation
70 147
Gain on disposal of equipment
-0
Inventory impairments and write offs
15 41
Loss (gain) on foreign currency transactions
8 -7
Accounts receivable
621 259
Inventory
516 -337
Prepaid expenses and other current assets
-91 85
Right-of-use assets
-90 -175
Accounts payable
312 -24
Other assets
-0
Accrued expenses
380 277
Lease liabilities
-85 -168
Net cash provided by (used in) operating activities
99 1,316
Proceeds from sale of equipment
-0
Purchase of property and equipment
-0
Net cash used in investing activities
-0
Principal payments on finance lease liability
2 2
Net cash used in financing activities
-2 -2
Net increase (decrease) in cash and cash equivalents
97 1,314
Cash and cash equivalents at beginning of period
3,760 -
Cash and cash equivalents at end of period
5,171 -
Unit: Thousand (K) dollars

Time Plot

Show the time plot by selecting a row from the table.

NEPHROS INC (NEPH)

NEPHROS INC (NEPH)